ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 277 filers reported holding ICU MED INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $734,648 | +208.1% | 6,173 | +361.4% | 0.00% | – |
| Q2 2023 | $238,419 | -66.1% | 1,338 | -68.6% | 0.00% | – |
| Q1 2023 | $702,400 | +51.0% | 4,258 | +44.2% | 0.00% | – |
| Q4 2022 | $465,038 | -40.9% | 2,953 | -43.4% | 0.00% | -100.0% |
| Q3 2022 | $787,000 | +79.7% | 5,219 | +96.5% | 0.00% | – |
| Q2 2022 | $438,000 | -93.1% | 2,656 | -90.7% | 0.00% | -100.0% |
| Q1 2022 | $6,345,000 | +7.8% | 28,498 | +14.9% | 0.00% | +33.3% |
| Q4 2021 | $5,886,000 | +72.3% | 24,800 | +69.4% | 0.00% | +50.0% |
| Q3 2021 | $3,416,000 | +172.2% | 14,643 | +140.1% | 0.00% | +100.0% |
| Q2 2021 | $1,255,000 | -38.1% | 6,099 | -38.2% | 0.00% | 0.0% |
| Q1 2021 | $2,027,000 | +124.2% | 9,867 | +133.9% | 0.00% | 0.0% |
| Q4 2020 | $904,000 | +33.1% | 4,218 | +13.4% | 0.00% | – |
| Q3 2020 | $679,000 | -62.7% | 3,718 | -62.3% | 0.00% | -100.0% |
| Q2 2020 | $1,819,000 | -22.6% | 9,872 | -15.3% | 0.00% | -50.0% |
| Q1 2020 | $2,351,000 | +35.0% | 11,649 | +25.1% | 0.00% | +100.0% |
| Q4 2019 | $1,742,000 | +235.6% | 9,314 | +186.8% | 0.00% | – |
| Q3 2019 | $519,000 | -43.0% | 3,248 | -10.1% | 0.00% | -100.0% |
| Q2 2019 | $911,000 | -53.8% | 3,614 | -56.1% | 0.00% | -50.0% |
| Q1 2019 | $1,972,000 | +48.0% | 8,240 | +42.0% | 0.00% | +100.0% |
| Q4 2018 | $1,332,000 | -54.3% | 5,801 | -43.7% | 0.00% | -66.7% |
| Q3 2018 | $2,916,000 | +218.7% | 10,312 | +230.5% | 0.00% | +200.0% |
| Q2 2018 | $915,000 | -27.3% | 3,120 | -37.4% | 0.00% | 0.0% |
| Q1 2018 | $1,258,000 | -4.2% | 4,984 | -18.0% | 0.00% | 0.0% |
| Q4 2017 | $1,313,000 | -42.5% | 6,075 | -50.5% | 0.00% | -50.0% |
| Q3 2017 | $2,283,000 | -23.0% | 12,280 | -28.6% | 0.00% | -33.3% |
| Q2 2017 | $2,965,000 | +130.6% | 17,190 | +104.3% | 0.00% | +200.0% |
| Q1 2017 | $1,286,000 | -59.7% | 8,415 | -61.1% | 0.00% | -66.7% |
| Q4 2016 | $3,188,000 | +151.8% | 21,639 | +115.9% | 0.00% | +200.0% |
| Q3 2016 | $1,266,000 | +91.5% | 10,021 | +70.8% | 0.00% | 0.0% |
| Q2 2016 | $661,000 | -39.5% | 5,866 | -44.1% | 0.00% | 0.0% |
| Q1 2016 | $1,092,000 | +443.3% | 10,489 | +489.6% | 0.00% | – |
| Q4 2015 | $201,000 | +737.5% | 1,779 | +701.4% | 0.00% | – |
| Q3 2015 | $24,000 | -40.0% | 222 | -46.4% | 0.00% | – |
| Q2 2015 | $40,000 | -39.4% | 414 | -41.8% | 0.00% | – |
| Q1 2015 | $66,000 | 0.0% | 711 | -11.0% | 0.00% | – |
| Q4 2014 | $66,000 | -28.3% | 799 | -44.6% | 0.00% | – |
| Q3 2014 | $92,000 | +22.7% | 1,441 | +17.1% | 0.00% | – |
| Q2 2014 | $75,000 | -12.8% | 1,231 | -14.2% | 0.00% | – |
| Q1 2014 | $86,000 | -76.9% | 1,435 | -75.4% | 0.00% | – |
| Q4 2013 | $372,000 | -10.1% | 5,843 | -4.0% | 0.00% | – |
| Q3 2013 | $414,000 | +546.9% | 6,087 | +590.1% | 0.00% | – |
| Q2 2013 | $64,000 | – | 882 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |